Methodological Issues in the Clinical Validation of Biomarkers for Alzheimer’s Disease: The Paradigmatic Example of CSF

The use of biomarkers is profoundly transforming medical research and practice. Their adoption has triggered major advancements in the field of Alzheimer’s disease (AD) over the past years. For instance, the analysis of the cerebrospinal fluid (CSF) and neuroimaging changes indicative of neuronal lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Canevelli, Marco, Bacigalupo, Ilaria, Gervasi, Giuseppe, Lacorte, Eleonora, Massari, Marco, Mayer, Flavia, Vanacore, Nicola, Cesari, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812267/
https://www.ncbi.nlm.nih.gov/pubmed/31680936
http://dx.doi.org/10.3389/fnagi.2019.00282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812267/
https://www.ncbi.nlm.nih.gov/pubmed/31680936
http://dx.doi.org/10.3389/fnagi.2019.00282

Ejemplares similares